skip to Main Content

Promising New Pancreatic Cancer Treatment Developed by OSU and OHSU Researchers

Newsfeed image, light gray text on dark gray background
A team of scientists in Oregon have developed a new therapy that, if approved, could significantly increase a patient’s odds of surviving pancreatic cancer. The scientists are at both Oregon State University’s (OSU) College of Pharmacy and at the Brenden-Colson Center for Pancreatic Care at Oregon Health and Science University’s (OHSU) Knight Cancer Institute.

Doctors say it depends on when the cancer is first detected, but the odds of surviving usually range from 11%-30%. Pancreatic cancer is the fourth deadliest type of cancer. Read more . . . 

Back To Top